Zai Lab Gross Profit 2016-2022 | ZLAB
Zai Lab gross profit from 2016 to 2022. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
Zai Lab Annual Gross Profit
(Millions of US $) |
| 2021 |
$92 |
| 2020 |
$32 |
| 2019 |
$9 |
| 2018 |
$0 |
| 2017 |
$ |
| 2016 |
$ |
| 2015 |
$ |
Zai Lab Quarterly Gross Profit
(Millions of US $) |
| 2022-03-31 |
$31 |
| 2021-12-31 |
$22 |
| 2021-09-30 |
$31 |
| 2021-06-30 |
$26 |
| 2021-03-31 |
$13 |
| 2020-12-31 |
$8 |
| 2020-09-30 |
$10 |
| 2020-06-30 |
|
| 2020-03-31 |
$6 |
| 2019-12-31 |
|
| 2019-09-30 |
|
| 2019-06-30 |
|
| 2018-12-31 |
|
| 2017-12-31 |
|
| 2017-06-30 |
|
| 2016-12-31 |
|
| 2015-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$3.334B |
$0.144B |
|
Zai Lab Ltd is a biopharmaceutical company. It focused on medicines for cancer, autoimmune and infectious diseases primarily in China. The company's product pipeline consists of ZL-2306, ZL-2401, ZL-2301, ZL-3101, ZL-2302 and ZL-1101 which are in clinical stage. Zai Lab Ltd is based in Pudong, China.
|
